Research brief
Idiopathic normal pressure hydrocephalus (iNPH) is characterised by issues with walking, thinking, and bladder control, often managed with cerebrospinal fluid shunting. However, the success of this treatment varies. Recent studies indicate that Alzheimer’s disease (AD) pathology plays a role in these differences. A systematic review and meta-analysis investigated whether AD co-pathology affects outcomes after shunting in iNPH patients. The research shows that while short-term cognitive outcomes remain similar, long-term cognitive recovery is less favourable for those with AD co-pathology. Gait improvements are more noticeable in the short term for patients without AD pathology.
Key points
- AD pathology hinders long-term cognitive recovery after shunting.
- Short-term gait improvements are better in patients without AD.
- Urinary outcomes are not influenced by AD pathology.
Understanding iNPH and Its Treatment
Idiopathic normal pressure hydrocephalus (iNPH) can cause serious problems with walking, thinking, and bladder control. Treatment often involves cerebrospinal fluid shunting, which can alleviate these symptoms. However, not all patients experience the same level of success, leading researchers to explore factors that might affect treatment outcomes.
The Role of Alzheimer’s Co-Pathology
A systematic review and meta-analysis examined whether Alzheimer’s disease (AD) co-pathology influences the results of shunt procedures in iNPH patients. The study reviewed data from 16 studies involving 1,825 patients, with some included in a meta-analysis. The findings showed that while short-term cognitive outcomes were similar regardless of AD pathology, long-term cognitive recovery was worse in patients with AD co-pathology.
Implications for Treatment
These findings suggest that AD pathology should not automatically rule out shunting for iNPH patients. Assessing AD biomarkers before shunting could help predict outcomes and allow for more personalised postoperative care. This approach may help clinicians determine which patients will benefit most from shunting, particularly regarding cognitive recovery.
Discover more from Neurospan
Subscribe to get the latest posts sent to your email.
